1. Endo thinks it has the financial flexibility to weather the storm of opioid settlements — Takeda acquires celiac-focused PvP Biologics — Iovance jumps on buyout rumors — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Time for a new CEO?

Discussion in 'Quest Diagnostics' started by anonymous, Oct 30, 2019 at 11:28 PM.

  1. anonymous

    anonymous Guest

    While the stock price is near its high, the revenue growth and margins are stagnant. Any ideas?
     
  2. anonymous

    anonymous Guest

    This is definitely not your CEO posting from the 4 Seasons in Aspen, CO.

    Hey peons! I hear the CEO is about to get a lifetime appointment at DGX! Like hell they’ll find some better! Ha Ha! Enjoy your day off tomorrow that I graciously approved for you to have. I expect you to be back to work at 7:30 AM on Friday and don’t even think about those Black Friday sales. I’ll be on my first black diamond by 10 suckers! Ha Ha!

    Signed,

    Anonymous CEO
     
  3. anonymous

    anonymous Guest

    The answer is a resounding NO
     
  4. anonymous

    anonymous Guest

    Like the Pope, CEO for life.